Patent · 2024 · pending
Treatment of CDHR3 Related Diseases and Disorders
siRNA and antisense oligonucleotides targeting CDHR3, for conditions associated with CDHR3 variants.
- Filings
- 1
- Status
- Pending
- First priority
- Apr 19, 2024
Patent · 2024 · pending
siRNA and antisense oligonucleotides targeting CDHR3, for conditions associated with CDHR3 variants.